View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAVEVA Group 향후 성장Future 기준 점검 4/6핵심 정보39.7%이익 성장률43.07%EPS 성장률Software 이익 성장16.4%매출 성장률8.7%향후 자기자본이익률6.70%애널리스트 커버리지Good마지막 업데이트n/a최근 향후 성장 업데이트Price Target Changed • Apr 28Price target decreased to UK£33.83Down from UK£36.63, the current price target is an average from 16 analysts. New target price is 65% above last closing price of UK£20.54. Stock is down 42% over the past year. The company is forecast to post earnings per share of UK£0.072 for next year compared to UK£0.11 last year.Price Target Changed • Feb 28Price target decreased to UK£39.60Down from UK£42.71, the current price target is an average from 14 analysts. New target price is 59% above last closing price of UK£24.90. Stock is down 28% over the past year. The company is forecast to post a net loss per share of UK£0.0043 compared to earnings per share of UK£0.11 last year.Major Estimate Revision • Jun 01Consensus EPS estimates fall to UK£0.40The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from UK£1.27b to UK£1.25b. EPS estimate also fell from UK£0.59 to UK£0.40. Net income forecast to grow 357% next year vs 5.2% decline forecast for Software industry in the United Kingdom. Consensus price target broadly unchanged at UK£41.65. Share price rose 6.8% to UK£34.99 over the past week.Price Target Changed • Nov 26Price target lowered to UK£39.56Down from UK£43.41, the current price target is an average from 11 analysts. The new target price is 19% above the current share price of UK£33.18. As of last close, the stock is down 27% over the past year.Major Estimate Revision • Nov 12Analysts lower EPS estimates to UK£0.33The 2021 consensus revenue estimate was lowered from UK£800.0m to UK£791.9m. Earning per share (EPS) estimate was also lowered from UK£0.44 to UK£0.33 for the same period. Net income is expected to grow by 127% next year compared to 12% decline forecast for the Software industry in the United Kingdom. The consensus price target was lowered from UK£44.84 to UK£43.66. Share price is down by 1.4% to UK£41.03 over the past week.모든 업데이트 보기Recent updates공시 • Jan 19+ 5 more updatesAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share IndexAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share IndexRecent Insider Transactions • Aug 03CTO and Executive VP of R&D recently sold UK£57k worth of stockOn the 26th of July, Andrew McCloskey sold around 2k shares on-market at roughly UK£23.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of UK£252k more than they bought in the last 12 months.Upcoming Dividend • Jun 30Upcoming dividend of UK£0.24 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 05 August 2022. The company is not currently making a profit and its cash payout ratio is 85%. Trailing yield: 1.7%. Lower than top quartile of British dividend payers (5.2%). Lower than average of industry peers (2.2%).Reported Earnings • Jun 09Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: UK£0.21 loss per share (down from UK£0.11 profit in FY 2021). Revenue: UK£1.19b (up 45% from FY 2021). Net loss: UK£62.6m (down 352% from profit in FY 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 12%, compared to a 26% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.Board Change • Jun 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Anne Stevens was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • May 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be UK£26.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.Price Target Changed • Apr 28Price target decreased to UK£33.83Down from UK£36.63, the current price target is an average from 16 analysts. New target price is 65% above last closing price of UK£20.54. Stock is down 42% over the past year. The company is forecast to post earnings per share of UK£0.072 for next year compared to UK£0.11 last year.Buying Opportunity • Apr 27Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 32%. The fair value is estimated to be UK£27.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.Board Change • Mar 29High number of new directorsIndependent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021.Recent Insider Transactions • Mar 11CTO and Executive VP of R&D recently sold UK£159k worth of stockOn the 7th of March, Andrew McCloskey sold around 7k shares on-market at roughly UK£24.03 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought UK£320k more than they sold in the last 12 months.Price Target Changed • Feb 28Price target decreased to UK£39.60Down from UK£42.71, the current price target is an average from 14 analysts. New target price is 59% above last closing price of UK£24.90. Stock is down 28% over the past year. The company is forecast to post a net loss per share of UK£0.0043 compared to earnings per share of UK£0.11 last year.Buying Opportunity • Feb 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be UK£33.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% per annum over the last 3 years. The company became loss making over the last year.Upcoming Dividend • Dec 30Upcoming dividend of UK£0.13 per shareEligible shareholders must have bought the stock before 06 January 2022. Payment date: 04 February 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.5%).Recent Insider Transactions Derivative • Dec 15Insider exercised options and sold UK£120k worth of stockOn the 13th of December, Lisa Johnston exercised options to acquire 4k shares at no cost and sold these for an average price of UK£32.72 per share. This trade did not impact their existing holding. Since September 2021, Lisa has owned 3.57k shares directly. Company insiders have collectively sold UK£4.5m more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • Nov 11First half 2022 earnings released: UK£0.27 loss per share (vs UK£0.13 loss in 1H 2021)The company reported a mediocre first half result with increased losses and weaker control over costs, although revenues improved. First half 2022 results: Revenue: UK£480.9m (up 45% from 1H 2021). Net loss: UK£81.5m (loss widened 302% from 1H 2021). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Board Change • Nov 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions Derivative • Oct 02Deputy CEO exercised options and sold UK£654k worth of stockOn the 28th of September, James Kidd exercised options to acquire 18k shares at no cost and sold these for an average price of UK£37.26 per share. This trade did not impact their existing holding. Since December 2020, James' direct individual holding has increased from 52.56k shares to 112.60k. Company insiders have collectively sold UK£3.9m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Sep 17CTO and Executive VP of R&D exercised options and sold UK£56k worth of stockOn the 14th of September, Andrew McCloskey exercised options to acquire 1k shares at no cost and sold these for an average price of UK£38.91 per share. This trade did not impact their existing holding. Since December 2020, Andrew's direct individual holding has increased from 594.00 shares to 2.37k. Company insiders have collectively sold UK£3.1m more than they bought, via options and on-market transactions in the last 12 months.Upcoming Dividend • Jul 01Upcoming dividend of UK£0.23 per shareEligible shareholders must have bought the stock before 08 July 2021. Payment date: 04 August 2021. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.6%).Recent Insider Transactions Derivative • Jul 01Chief Revenue Officer exercised options and sold UK£170k worth of stockOn the 28th of June, Steen Lomholt-Thomsen exercised options to acquire 5k shares at no cost and sold these for an average price of UK£37.43 per share. This trade did not impact their existing holding. Since December 2020, Steen's direct individual holding has increased from 3.60k shares to 6.41k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Jun 04Deputy CEO exercised options and sold UK£125k worth of stockOn the 2nd of June, James Kidd exercised options to acquire 4k shares at no cost and sold these for an average price of UK£34.85 per share. This trade did not impact their existing holding. Since September 2020, James' direct individual holding has increased from 47.06k shares to 105.03k. Company insiders have collectively sold UK£4.3m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • Jun 03CEO & Non-Executive Vice Chairman recently bought UK£479k worth of stockOn the 1st of June, Peter Herweck bought around 14k shares on-market at roughly UK£35.48 per share. This was the largest purchase by an insider in the last 3 months. Peter has been a buyer over the last 12 months, purchasing a net total of UK£268k worth in shares.Major Estimate Revision • Jun 01Consensus EPS estimates fall to UK£0.40The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from UK£1.27b to UK£1.25b. EPS estimate also fell from UK£0.59 to UK£0.40. Net income forecast to grow 357% next year vs 5.2% decline forecast for Software industry in the United Kingdom. Consensus price target broadly unchanged at UK£41.65. Share price rose 6.8% to UK£34.99 over the past week.Reported Earnings • May 27Full year 2021 earnings released: EPS UK£0.11 (vs UK£0.43 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£820.4m (down 1.6% from FY 2020). Net income: UK£24.8m (down 65% from FY 2020). Profit margin: 3.0% (down from 8.4% in FY 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Executive Departure • May 21Finance Director & Company Secretary has left the companyOn the 17th of May, David Ward's tenure as Finance Director & Company Secretary ended after 3.2 years in the role. As of March 2021, David personally held 10.84k shares (UK£371k worth at the time). David is the only executive to leave the company over the last 12 months.Recent Insider Transactions Derivative • Feb 26CEO & Executive Director exercised options and sold UK£1.1m worth of stockOn the 24th of February, Craig Hayman exercised options to acquire 32k shares at no cost and sold these for an average price of UK£35.51 per share. This trade did not impact their existing holding. For the year to March 2020, Craig's total compensation was 13% salary and 87% non-salary (Indicating these sales could comprise a meaningful part of their income for the year). Since December 2020, Craig's direct individual holding has increased from 69.83k shares to 124.15k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • Feb 13Finance Director & Company Secretary recently sold UK£152k worth of stockOn the 11th of February, David Ward sold around 4k shares on-market at roughly UK£37.75 per share. In the last 3 months, there was an even bigger sale from another insider worth UK£271k. Despite this recent sale, insiders have collectively bought UK£261k more than they sold in the last 12 months.Recent Insider Transactions • Jan 21Non-Executive Vice Chairman recently sold UK£271k worth of stockOn the 19th of January, Peter Herweck sold around 7k shares on-market at roughly UK£38.13 per share. This was the largest sale by an insider in the last 3 months. Peter has been a seller over the last 12 months, reducing personal holdings by UK£122k.Upcoming Dividend • Dec 31Upcoming Dividend of UK£0.12 Per ShareWill be paid on the 5th of February to those who are registered shareholders by the 7th of January. The trailing yield of 1.4% is below the top quartile of British dividend payers (4.7%), and is lower than industry peers (1.7%).Is New 90 Day High Low • Dec 01New 90-day low: UK£31.81The company is down 37% from its price of UK£50.34 on 02 September 2020. The British market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£17.96 per share.Price Target Changed • Nov 26Price target lowered to UK£39.56Down from UK£43.41, the current price target is an average from 11 analysts. The new target price is 19% above the current share price of UK£33.18. As of last close, the stock is down 27% over the past year.Recent Insider Transactions • Nov 20Deputy CEO recently bought UK£230k worth of stockOn the 16th of November, James Kidd bought around 6k shares on-market at roughly UK£41.69 per share. This was the largest purchase by an insider in the last 3 months. This was James' only on-market trade for the last 12 months.Major Estimate Revision • Nov 12Analysts lower EPS estimates to UK£0.33The 2021 consensus revenue estimate was lowered from UK£800.0m to UK£791.9m. Earning per share (EPS) estimate was also lowered from UK£0.44 to UK£0.33 for the same period. Net income is expected to grow by 127% next year compared to 12% decline forecast for the Software industry in the United Kingdom. The consensus price target was lowered from UK£44.84 to UK£43.66. Share price is down by 1.4% to UK£41.03 over the past week.Recent Insider Transactions • Nov 07Independent Non-Executive Director recently bought UK£163k worth of stockOn the 6th of November, Jennifer Allerton bought around 4k shares on-market at roughly UK£40.81 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£455k more in shares than they have sold in the last 12 months.Reported Earnings • Nov 07First half 2021 earnings released: UK£0.13 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£332.6m (down 15% from 1H 2020). Net loss: UK£20.3m (down 213% from profit in 1H 2020).Analyst Estimate Surprise Post Earnings • Nov 07Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.4%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 31% growth forecast for the Software industry in the United Kingdom.Is New 90 Day High Low • Nov 02New 90-day low: UK£41.81The company is down 1.0% from its price of UK£42.22 on 04 August 2020. The British market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£18.40 per share.이익 및 매출 성장 예측LSE:AVV - 애널리스트 향후 추정치 및 과거 재무 데이터 (GBP Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/20251,58313939138693/31/20241,45894334337113/31/20231,35643303276119/30/20221,256-61204215N/A6/30/20221,221-62167176N/A3/31/20221,185-63129137N/A12/31/20211,077-495462N/A9/30/2021969-36-22-13N/A6/30/2021895-61323N/A3/31/2021820254758N/A12/31/2020797287389N/A9/30/202077532100119N/A6/30/202080451101120N/A3/31/202083470103122N/A12/31/201982864104119N/A9/30/201982258105117N/A6/30/201979446117127N/A3/31/201976734129137N/A12/31/201868731103109N/A9/30/2018608287680N/A6/30/2018547346871N/A3/31/2018486416063N/A12/31/2017455376971N/A9/30/2017441348082N/A6/30/2017434368691N/A3/31/20174333894101N/A3/31/201641741N/A87N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: AVV 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(1%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: AVV (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: AVV 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: AVV 의 수익(연간 8.7%)이 UK 시장(연간 4.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: AVV 의 수익(연간 8.7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: AVV의 자본 수익률은 3년 후 6.7%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YSoftware 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/01/20 04:04종가2023/01/18 00:00수익2022/09/30연간 수익2022/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스AVEVA Group plc는 11명의 분석가가 다루고 있습니다. 이 중 11명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Gal MundaBerenbergNicholas GreenBernsteinFrederic Emile BoulanBofA Global Research8명의 분석가 더 보기
Price Target Changed • Apr 28Price target decreased to UK£33.83Down from UK£36.63, the current price target is an average from 16 analysts. New target price is 65% above last closing price of UK£20.54. Stock is down 42% over the past year. The company is forecast to post earnings per share of UK£0.072 for next year compared to UK£0.11 last year.
Price Target Changed • Feb 28Price target decreased to UK£39.60Down from UK£42.71, the current price target is an average from 14 analysts. New target price is 59% above last closing price of UK£24.90. Stock is down 28% over the past year. The company is forecast to post a net loss per share of UK£0.0043 compared to earnings per share of UK£0.11 last year.
Major Estimate Revision • Jun 01Consensus EPS estimates fall to UK£0.40The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from UK£1.27b to UK£1.25b. EPS estimate also fell from UK£0.59 to UK£0.40. Net income forecast to grow 357% next year vs 5.2% decline forecast for Software industry in the United Kingdom. Consensus price target broadly unchanged at UK£41.65. Share price rose 6.8% to UK£34.99 over the past week.
Price Target Changed • Nov 26Price target lowered to UK£39.56Down from UK£43.41, the current price target is an average from 11 analysts. The new target price is 19% above the current share price of UK£33.18. As of last close, the stock is down 27% over the past year.
Major Estimate Revision • Nov 12Analysts lower EPS estimates to UK£0.33The 2021 consensus revenue estimate was lowered from UK£800.0m to UK£791.9m. Earning per share (EPS) estimate was also lowered from UK£0.44 to UK£0.33 for the same period. Net income is expected to grow by 127% next year compared to 12% decline forecast for the Software industry in the United Kingdom. The consensus price target was lowered from UK£44.84 to UK£43.66. Share price is down by 1.4% to UK£41.03 over the past week.
공시 • Jan 19+ 5 more updatesAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share IndexAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share Index
Recent Insider Transactions • Aug 03CTO and Executive VP of R&D recently sold UK£57k worth of stockOn the 26th of July, Andrew McCloskey sold around 2k shares on-market at roughly UK£23.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of UK£252k more than they bought in the last 12 months.
Upcoming Dividend • Jun 30Upcoming dividend of UK£0.24 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 05 August 2022. The company is not currently making a profit and its cash payout ratio is 85%. Trailing yield: 1.7%. Lower than top quartile of British dividend payers (5.2%). Lower than average of industry peers (2.2%).
Reported Earnings • Jun 09Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: UK£0.21 loss per share (down from UK£0.11 profit in FY 2021). Revenue: UK£1.19b (up 45% from FY 2021). Net loss: UK£62.6m (down 352% from profit in FY 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 12%, compared to a 26% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.
Board Change • Jun 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Anne Stevens was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • May 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be UK£26.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.
Price Target Changed • Apr 28Price target decreased to UK£33.83Down from UK£36.63, the current price target is an average from 16 analysts. New target price is 65% above last closing price of UK£20.54. Stock is down 42% over the past year. The company is forecast to post earnings per share of UK£0.072 for next year compared to UK£0.11 last year.
Buying Opportunity • Apr 27Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 32%. The fair value is estimated to be UK£27.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.
Board Change • Mar 29High number of new directorsIndependent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021.
Recent Insider Transactions • Mar 11CTO and Executive VP of R&D recently sold UK£159k worth of stockOn the 7th of March, Andrew McCloskey sold around 7k shares on-market at roughly UK£24.03 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought UK£320k more than they sold in the last 12 months.
Price Target Changed • Feb 28Price target decreased to UK£39.60Down from UK£42.71, the current price target is an average from 14 analysts. New target price is 59% above last closing price of UK£24.90. Stock is down 28% over the past year. The company is forecast to post a net loss per share of UK£0.0043 compared to earnings per share of UK£0.11 last year.
Buying Opportunity • Feb 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be UK£33.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% per annum over the last 3 years. The company became loss making over the last year.
Upcoming Dividend • Dec 30Upcoming dividend of UK£0.13 per shareEligible shareholders must have bought the stock before 06 January 2022. Payment date: 04 February 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.5%).
Recent Insider Transactions Derivative • Dec 15Insider exercised options and sold UK£120k worth of stockOn the 13th of December, Lisa Johnston exercised options to acquire 4k shares at no cost and sold these for an average price of UK£32.72 per share. This trade did not impact their existing holding. Since September 2021, Lisa has owned 3.57k shares directly. Company insiders have collectively sold UK£4.5m more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • Nov 11First half 2022 earnings released: UK£0.27 loss per share (vs UK£0.13 loss in 1H 2021)The company reported a mediocre first half result with increased losses and weaker control over costs, although revenues improved. First half 2022 results: Revenue: UK£480.9m (up 45% from 1H 2021). Net loss: UK£81.5m (loss widened 302% from 1H 2021). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Board Change • Nov 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions Derivative • Oct 02Deputy CEO exercised options and sold UK£654k worth of stockOn the 28th of September, James Kidd exercised options to acquire 18k shares at no cost and sold these for an average price of UK£37.26 per share. This trade did not impact their existing holding. Since December 2020, James' direct individual holding has increased from 52.56k shares to 112.60k. Company insiders have collectively sold UK£3.9m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Sep 17CTO and Executive VP of R&D exercised options and sold UK£56k worth of stockOn the 14th of September, Andrew McCloskey exercised options to acquire 1k shares at no cost and sold these for an average price of UK£38.91 per share. This trade did not impact their existing holding. Since December 2020, Andrew's direct individual holding has increased from 594.00 shares to 2.37k. Company insiders have collectively sold UK£3.1m more than they bought, via options and on-market transactions in the last 12 months.
Upcoming Dividend • Jul 01Upcoming dividend of UK£0.23 per shareEligible shareholders must have bought the stock before 08 July 2021. Payment date: 04 August 2021. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.6%).
Recent Insider Transactions Derivative • Jul 01Chief Revenue Officer exercised options and sold UK£170k worth of stockOn the 28th of June, Steen Lomholt-Thomsen exercised options to acquire 5k shares at no cost and sold these for an average price of UK£37.43 per share. This trade did not impact their existing holding. Since December 2020, Steen's direct individual holding has increased from 3.60k shares to 6.41k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Jun 04Deputy CEO exercised options and sold UK£125k worth of stockOn the 2nd of June, James Kidd exercised options to acquire 4k shares at no cost and sold these for an average price of UK£34.85 per share. This trade did not impact their existing holding. Since September 2020, James' direct individual holding has increased from 47.06k shares to 105.03k. Company insiders have collectively sold UK£4.3m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • Jun 03CEO & Non-Executive Vice Chairman recently bought UK£479k worth of stockOn the 1st of June, Peter Herweck bought around 14k shares on-market at roughly UK£35.48 per share. This was the largest purchase by an insider in the last 3 months. Peter has been a buyer over the last 12 months, purchasing a net total of UK£268k worth in shares.
Major Estimate Revision • Jun 01Consensus EPS estimates fall to UK£0.40The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from UK£1.27b to UK£1.25b. EPS estimate also fell from UK£0.59 to UK£0.40. Net income forecast to grow 357% next year vs 5.2% decline forecast for Software industry in the United Kingdom. Consensus price target broadly unchanged at UK£41.65. Share price rose 6.8% to UK£34.99 over the past week.
Reported Earnings • May 27Full year 2021 earnings released: EPS UK£0.11 (vs UK£0.43 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£820.4m (down 1.6% from FY 2020). Net income: UK£24.8m (down 65% from FY 2020). Profit margin: 3.0% (down from 8.4% in FY 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Executive Departure • May 21Finance Director & Company Secretary has left the companyOn the 17th of May, David Ward's tenure as Finance Director & Company Secretary ended after 3.2 years in the role. As of March 2021, David personally held 10.84k shares (UK£371k worth at the time). David is the only executive to leave the company over the last 12 months.
Recent Insider Transactions Derivative • Feb 26CEO & Executive Director exercised options and sold UK£1.1m worth of stockOn the 24th of February, Craig Hayman exercised options to acquire 32k shares at no cost and sold these for an average price of UK£35.51 per share. This trade did not impact their existing holding. For the year to March 2020, Craig's total compensation was 13% salary and 87% non-salary (Indicating these sales could comprise a meaningful part of their income for the year). Since December 2020, Craig's direct individual holding has increased from 69.83k shares to 124.15k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • Feb 13Finance Director & Company Secretary recently sold UK£152k worth of stockOn the 11th of February, David Ward sold around 4k shares on-market at roughly UK£37.75 per share. In the last 3 months, there was an even bigger sale from another insider worth UK£271k. Despite this recent sale, insiders have collectively bought UK£261k more than they sold in the last 12 months.
Recent Insider Transactions • Jan 21Non-Executive Vice Chairman recently sold UK£271k worth of stockOn the 19th of January, Peter Herweck sold around 7k shares on-market at roughly UK£38.13 per share. This was the largest sale by an insider in the last 3 months. Peter has been a seller over the last 12 months, reducing personal holdings by UK£122k.
Upcoming Dividend • Dec 31Upcoming Dividend of UK£0.12 Per ShareWill be paid on the 5th of February to those who are registered shareholders by the 7th of January. The trailing yield of 1.4% is below the top quartile of British dividend payers (4.7%), and is lower than industry peers (1.7%).
Is New 90 Day High Low • Dec 01New 90-day low: UK£31.81The company is down 37% from its price of UK£50.34 on 02 September 2020. The British market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£17.96 per share.
Price Target Changed • Nov 26Price target lowered to UK£39.56Down from UK£43.41, the current price target is an average from 11 analysts. The new target price is 19% above the current share price of UK£33.18. As of last close, the stock is down 27% over the past year.
Recent Insider Transactions • Nov 20Deputy CEO recently bought UK£230k worth of stockOn the 16th of November, James Kidd bought around 6k shares on-market at roughly UK£41.69 per share. This was the largest purchase by an insider in the last 3 months. This was James' only on-market trade for the last 12 months.
Major Estimate Revision • Nov 12Analysts lower EPS estimates to UK£0.33The 2021 consensus revenue estimate was lowered from UK£800.0m to UK£791.9m. Earning per share (EPS) estimate was also lowered from UK£0.44 to UK£0.33 for the same period. Net income is expected to grow by 127% next year compared to 12% decline forecast for the Software industry in the United Kingdom. The consensus price target was lowered from UK£44.84 to UK£43.66. Share price is down by 1.4% to UK£41.03 over the past week.
Recent Insider Transactions • Nov 07Independent Non-Executive Director recently bought UK£163k worth of stockOn the 6th of November, Jennifer Allerton bought around 4k shares on-market at roughly UK£40.81 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£455k more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 07First half 2021 earnings released: UK£0.13 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£332.6m (down 15% from 1H 2020). Net loss: UK£20.3m (down 213% from profit in 1H 2020).
Analyst Estimate Surprise Post Earnings • Nov 07Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.4%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 31% growth forecast for the Software industry in the United Kingdom.
Is New 90 Day High Low • Nov 02New 90-day low: UK£41.81The company is down 1.0% from its price of UK£42.22 on 04 August 2020. The British market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£18.40 per share.